Prevalence of hepatitis G virus in patients with hepatocellular carcinoma

Journal of Viral Hepatitis

Volumn 4, Issue 6, 1997, Pages 411-414

  Muller C ^a   Pfeffel, E ^a   Peck Radosavljevic, M ^a   Petermann, D ^a   Oesterreicher, C ^a   Pidlich, J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hepatitis G virus; Hepatocellular carcinoma

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD; FEMALE; FLAVIVIRUS; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PREVALENCE; VIROLOGY; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; FEMALE; FLAVIVIRIDAE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RNA, VIRAL;

EID: 0031303893     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00071.x     Document Type: Article

References (17)

1. Parkin DM, Stjernward J, Muir CS. Estimates of the worldwide frequency of twelve major cancers. WHO Bull 1984; 62: 163-182.
2. Lu SN, Lin TM, Chen CJ et al. A case control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988; 62: 2051-2055.
3. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma. Epidemiologic considerations. Hepatology 1982; 2 (suppl): 21S-26S.
4. Colombo M, Choo QL, Del Ninno E et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. The Lancet 1989; ii: 1006-1008.
5. Bruix J, Calvet X, Costa J et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. The Lancet 1989; ii: 1004-1006.
6. Simons JN, Leary TP, Dawson GJ et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-569.
7. Linnen J, Wages J, Zhang-Keck Z-Y et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-509.
8. Zuckerman AJ. Alphabet of hepatitis viruses. The Lancet 1996; i: 558-559.
9. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 38 900 necropsies. Cancer 1954; 7: 462-503.
10. Oesterreicher CH, Hammer J, Koch U et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995; 48: 1967-1971.
11. Berg T, Dirla U, Naumann U et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol 1996; 25: 763-768.
12. Berg T, Naumann U, Fukumoto T et al. GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation. Transplantation 1996; 62: 711-714.
13. Dawson GJ, Schlauder GG, Pilot-Matias TJ et al. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol 1996; 50: 97-103.
14. Schleicher S, Chaves RL, Dehmer T, Gregor M, Hess G, Flehmig B. Identification of GBV-C hepatitis G RNA in chronic hepatitis C patients. J Med Virol 1996; 50: 71-74.
15. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132.
16. Alter MJ, Gallagher M, Morris TT et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 336: 741-746.
17. Alter HJ, Nakatsuji Y, Melpolder J et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754.